From: Subject: Best Dx/Best Rx: Infective Endocarditis Date: Wed, 3 Jun 2009 21:41:30 -0700 MIME-Version: 1.0 Content-Type: multipart/related; type="text/html"; boundary="----=_NextPart_000_020B_01C9E494.0E5D5460" X-MimeOLE: Produced By Microsoft MimeOLE V6.00.2900.5579 This is a multi-part message in MIME format. ------=_NextPart_000_020B_01C9E494.0E5D5460 Content-Type: text/html; charset="Windows-1252" Content-Transfer-Encoding: quoted-printable Content-Location: http://www.acpmedicine.com/acp/newrxdx/rxdx/dxrx0718.htm Best Dx/Best Rx: Infective Endocarditis




Infective=20 Endocarditis

David T. Durack, M.B., D.Phil.
Duke = University School=20 of Medicine

Adolf W. Karchmer, M.D.
Harvard Medical=20 School

Defin= ition/Key=20 Clinical Features
Diffe= rential=20 Diagnosis
Best = Tests
Best = Therapy
Best = References

Definition/Key=20 Clinical Features=20

  • Localized microbial infection of cardiac = valves or mural=20 endocardium caused by bacteria, fungi, rickettsiae, or = chlamydiae=20
Subacute Bacterial Endocarditis = (SBE)=20
  • Insidious onset=20
  • Fever=20
  • Sweats=20
  • Weakness=20
  • Myalgias=20
  • Arthralgias=20
  • Malaise=20
  • Anorexia=20
  • Fatigue=20
  • Splenomegaly, clubbing, and Osler nodes in = long-standing=20 SBE
Acute Bacterial=20 Endocarditis=20
  • Abrupt onset=20
  • Rigors=20
  • Fevers as high as 102.9=B0 to 105.1=B0 F = (39.4=B0 to 40.6=B0 C),=20 often remittent=20
  • Cardiac=20
    • Murmur=20
    • New aortic diastolic murmur suggests = dilatation of the=20 aortic annulus or eversion, rupture, or fenestration of an aortic=20 leaflet=20
    • Sudden onset of loud mitral pansystolic = murmur=20 suggests rupture of chorda tendineae or fenestration of a mitral = valve=20 leaflet=20
    • Congestive heart failure=20
    • Cardiac rhythm disturbances
    • Occasionally, pericarditis =
  • Cutaneous=20
    • Petechiae of the conjunctivae, oropharynx, = skin, and=20 legs=20
    • Linear subungual =93splinter=94 hemorrhages = of the lower=20 or middle nail bed=20
    • Osler nodes=20
    • Janeway lesions
  • Musculoskeletal=20
    • Myalgias=20
    • Arthralgias=20
    • Arthritis=20
    • Low back pain=20
    • Rheumatoid factor in up to 50% of patients = with=20 endocarditis for > 6 wk=20
    • Clubbing of fingers in < 15% of = patients=20
  • Ocular=20
    • Petechial hemorrhages, flame-shaped = hemorrhages, Roth=20 spots, and cotton-wool exudates in the retina =
  • Embolic=20
    • Significant arterial emboli occur in = 30%=9650% of=20 patients, causing the following:=20
      • Stroke=20
      • Monocular blindness=20
      • Acute abdominal pain, ileus, and = melena=20
      • Pain and gangrene in the = extremities=20
    • CNS emboli are common=20
    • Coronary emboli, often asymptomatic, can = cause=20 myocardial infarction=20
    • Pulmonary emboli common in right-sided = endocarditis,=20 causing pulmonary infarcts or focal pneumonitis =
  • Splenic=20
    • Splenomegaly in 15%=9630% of patients =
    • Splenic infarcts in up to 40% of = patients=20
    • Splenic abscesses in ~ 5% of patients =
  • Renal=20
    • Microscopic hematuria in ~ 50% of = patients=20
    • Embolic renal infarction=20
    • Diffuse membranoproliferative=20 glomerulonephritis
  • Mycotic aneurysms=20
    • Occur in any artery in 2%=968% of patients, = causing the=20 following:=20
      • Pain or headache=20
      • Pulsatile mass=20
      • Fever=20
      • Sudden expanding hematoma=20
      • Signs of major blood loss=20
  • Neurologic=20
    • Neurologic complications occur in 25%=9640% = of=20 cases=20
    • Strokes caused by cerebral embolisms in ~ = 15% of=20 cases, causing the following:=20
      • Altered level of consciousness=20
      • Seizures=20
      • Fluctuating focal neurologic signs=20
    • Cerebral aneurysms occur in 1%=965% of = cases, causing=20 the following:=20
      • Headache=20
      • Focal signs=20
      • Acute intracerebral or subarachnoid = hemorrhage=20 caused by rupture=20
      • Mild meningeal irritation resulting from = slow=20 leakage
    • Brain abscesses may occur in acute = endocarditis caused=20 by Staphylococcus aureus=20
    • Seizures
    Endocarditis Associated with Parenteral = Drug=20 Use=20
    • High fevers, chills, rigors, malaise, cough, = and=20 pleuritic chest pain=20
    • Septic pulmonary emboli causing sputum = production,=20 hemoptysis, and signs suggesting pneumonia=20
    • Cardiac murmurs=20
    • Tricuspid insufficiency=20
    • Metastatic infections=20
    • Neurologic manifestations=20
    • Peripheral emboli
      Prosthetic Valve Endocarditis =
      • Occurs in 1%=962% of cases at 1 yr and in = 4%=965% of cases=20 at 4 yr after implantation=20
      • Infection of perivalvular tissues=20
      • Valvular dysfunction=20
      • Myocardial abscesses=20
      • Fever=20
      • Petechiae, Roth spots, Osler nodes, Janeway=20 lesions=20
      • Emboli

        3D""=20=20 bac= k to=20 top
        Differential=20 Diagnosis
        =20
        • Tuberculosis, salmonellosis, gastrointestinal = and=20 genitourinary infections, and other disorders causing fever of = undetermined=20 origin=20
        • Juvenile rheumatoid arthritis, polymyalgia=20 rheumatica=20
        • Acute rheumatic fever=20
        • Marantic endocarditis=20
        • Polyarteritis nodosa=20
        • Systemic lupus erythematosus with = antiphospholipid=20 antibody syndrome=20
        • Cardiac myxoma=20
        • Neoplasms

        3D""=20=20 bac= k to=20 top
        Best=20 Tests=20
        • Echocardiography=20
          • Transthoracic echocardiography=20
            • For detecting vegetations in native valve=20 endocarditis: sensitivity, 60%; specificity, 90%=20
            • For detecting abscess: sensitivity, = 18%=9628%;=20 specificity, 99%
        • Transesophageal echocardiography=20
          • For detecting vegetations in native valve=20 endocarditis: sensitivity, 95%; specificity, 100%=20
          • For detecting abscess: sensitivity, = 76%=9687%;=20 specificity, 96%=20
          • Better than transthoracic for evaluating = patients with=20 suspected prosthetic valve endocarditis and for detecting = paravalvular=20 abscesses
        • Blood culture=20
          • Incubate for 5 days (Bartonella = species may=20 need > 5 days for isolation)=20
          • Blood cultures are negative in 5%=9620% of = patients with=20 endocarditis
        • Serologic tests=20
          • Can diagnose endocarditis caused by = Bartonella,=20 Legionella, and Brucella species; Chlamydia = psittaci=20 and Coxiella burnetii in cases of culture-negative=20 endocarditis
        • Duke criteria for the diagnosis of infective=20 endocarditis=20
          • Definite=20
            • Pathologic criteria=20
              • Microorganisms: demonstrated by culture = or=20 histologically in a vegetation, in a vegetation that has = embolized, or=20 in an intracardiac abscess specimen=20
              • Pathologic lesions: vegetation or = intracardiac=20 abscess confirmed by histologic examination showing active=20 endocarditis=20
              • Clinical criteria (see definition of = terms,=20 below)=20
                • Two major criteria=20
                • One major and three minor = criteria=20
                • Five minor criteria=20
          • Possible=20
            • Findings consistent with infective = endocarditis that=20 fall short of =93definite=94 but are not =93rejected=94 =
          • Rejected=20
            • Firm alternative diagnosis for = manifestations of=20 infective endocarditis=20
            • Resolution of endocarditis syndrome with = antibiotic=20 therapy for ≤ 4 days=20
            • No pathologic evidence of infective = endocarditis at=20 surgery or autopsy, with antibiotic therapy for ≤ 4 = days

        • Definitions of terms used in Duke criteria for = diagnosis=20 of infective endocarditis=20
          • Major criteria=20
            • Positive blood cultures for any one of the = following:=20
              • Typical microorganism consistent with = diagnosis=20 from two separate blood cultures
              • Viridans streptococci, Streptococcus = bovis,=20 or HACEK organisms (Haemophilus, Actinobacillus=20 actinomycetemcomitans, Cardiobacterium hominis,=20 Eikenella, Kingella)
              • Community-acquired S. aureus or=20 enterococci, in the absence of a primary focus
            • Persistently positive blood cultures, = defined as=20 microorganisms consistent with diagnosis from any one of the = following:=20
              • At least two blood samples drawn > 12 = hr=20 apart=20
              • Three of three or a majority of more = than three=20 blood cultures drawn, with first and last samples drawn at least = 1 hr=20 apart
          • Evidence of endocardial involvement=20
            • Echocardiogram positive for infective = endocarditis=20 (any one of the following)=20
              • Oscillating intracardiac mass on valve = or=20 supporting structures, in the path of regurgitant jets, or on = implanted=20 material, in the absence of an alternative anatomic = explanation=20
              • Abscess=20
              • New partial dehiscence of prosthetic = valve=20
              • New valvular regurgitation (changing of=20 preexisting murmur not sufficient)
          • Minor criteria=20
            • Predisposition: predisposing heart = condition or I.V.=20 drug use=20
            • Fever: temperature ≥ 100.4=B0 F = (38=B0 C)=20
            • Vascular phenomena: major arterial emboli, = septic=20 pulmonary infarcts, mycotic aneurysm, intracranial hemorrhage,=20 conjunctival hemorrhages, Janeway lesions=20
            • Immunologic phenomena: glomerulonephritis, = Osler=20 nodes, Roth spots, rheumatoid factor=20
            • Microbiologic evidence: positive blood = culture but=20 not meeting a major criterion (see above; excludes single positive = cultures for coagulase-negative staphylococci, diphtheroids, and = organisms=20 that do not commonly cause endocarditis) or serologic evidence of = active=20 infection with organism consistent with infective endocarditis =
            • Echocardiogram consistent with infective=20 endocarditis but not meeting a major criterion (see above)=20

        3D""=20=20 bac= k to=20 top
        Best=20 Therapy


        Drug Therapy

        • Effective treatment requires identification of = the=20 etiologic agent and determination of its antimicrobial = susceptibility=20
        • Antibiotic therapy for subacute or indolent = disease can=20 be delayed until results of blood cultures are known; in fulminant = infection=20 or valvular dysfunction requiring urgent surgical intervention, begin=20 empirical antibiotic therapy promptly after blood cultures have been=20 obtained=20
        • For prosthetic valve endocarditis, treat for = 6=968=20 wk

        Penicillin-Susceptible Viridans and Other=20 Nonenterococcal Streptococci (minimum inhibitory concentration [MIC] = < 0.2=20 =B5g/ml)

        • Penicillin G: preferred regimen=20
          • Dose: 12=9618 million units I.V. daily in = divided doses=20 q. 4 hr for 4 wk
        • Penicillin G + gentamicin or ceftriaxone: = preferred=20 regimen=20
          • Dose: penicillin G, dose as above; = gentamicin, 3 mg/kg=20 I.M. or I.V. daily in divided doses q. 8 hr for 2 wk (peak serum=20 concentration should be ~ 3 =B5g/ml and trough concentrations < 1 = =B5g/ml);=20 ceftriaxone, 2 g I.V. daily as a single dose for 2 wk =
        • Vancomycin: for patients with history of = penicillin=20 hypersensitivity
          • Dose: 30 mg/kg I.V. daily in divided doses = q. 12 hr=20 for 4 wk

        Relatively Penicillin-Resistant=20 Streptococci

        • MIC 0.2=960.5 =B5g/ml=20
          • Penicillin G + gentamicin: preferred = regimen=20
            • Dose: penicillin G, 20=9630 million units = I.V. daily=20 in divided doses q. 4 hr for 4 wk; gentamicin, 3 mg/kg I.M. or = I.V. daily=20 in divided doses q. 8 hr for 2 wk (peak serum concentration should = be ~ 3=20 =B5g/ml and trough concentrations < 1 =B5g/ml) =
        • MIC > 0.5 =B5g/ml
          • Penicillin G + gentamicin: preferred = regimen=20
            • Dose: penicillin G, 20=9630 million units = I.V. daily=20 in divided doses q. 4 hr for 4 wk; gentamicin, 3 mg/kg I.M. or = I.V. daily=20 in divided doses q. 8 hr for 4 wk (peak serum concentration should = be ~ 3=20 =B5g/ml and trough concentrations < 1 =B5g/ml) =
          • Vancomycin: regimen for patients with = history of=20 penicillin hypersensitivity
            • Dose: 30 mg/kg I.V. daily in divided doses = q. 12 hr=20 for 4 wk

        Enterococci

        • Penicillin G + gentamicin: preferred = regimen=20
          • Dose: penicillin G, 20=9630 million units = I.V. daily in=20 divided doses q. 4 hr for 4=966 wk; gentamicin, 3 mg/kg I.M. or I.V. = daily in=20 divided doses q. 8 hr for 4=966 wk (peak serum concentration should = be ~ 3=20 =B5g/ml and trough concentrations < 1 =B5g/ml)
        • Ampicillin + gentamicin=20
          • Dose: ampicillin, 12 g I.V. daily in divided = doses q.=20 4 hr for 4=966 wk; gentamicin, dose as above
        • Vancomycin + gentamicin: regimen for patients = with=20 history of penicillin hypersensitivity=20
          • Dose: vancomycin, 30 mg/kg I.V. daily in = divided doses=20 q. 12 hr for 4=966 wk; gentamicin, dose as above =

          Staphylococci (Methicillin Susceptible) in the = Absence=20 of Prosthetic Material

          • Nafcillin or oxacillin + gentamicin = (optional):=20 preferred regimen=20
            • Dose: nafcillin or oxacillin, 12 g I.V. = daily in=20 divided doses q. 4 hr for 4=966 wk; gentamicin, 3 mg/kg I.M. or I.V. = daily in=20 divided doses q. 8 hr for 3=965 days (peak serum concentration = should be ~ 3=20 =B5g/ml and trough concentrations <1 =B5g/ml)
          • Cefazolin + gentamicin (optional): alternative = regimen=20 for patients with history of penicillin hypersensitivity=20
            • Dose: cefazolin, 12 g I.V. daily in divided = doses q. 4=20 hr for 4=966 wk; gentamicin, dose as above
          • Vancomycin: alternative regimen for patients = with=20 history of penicillin hypersensitivity
            • Dose: 30 mg/kg I.V. daily in divided doses = q. 12 hr=20 for 4=966 wk

          Staphylococci (Methicillin Resistant) in the = Absence of=20 Prosthetic Material

          • Vancomycin
            • Dose as above

            Staphylococci (Methicillin Susceptible) in the = Presence=20 of Prosthetic Material

            • Nafcillin or oxacillin + rifampin + gentamicin =
              • Dose: nafcillin or oxacillin, 12 g I.V. = daily in=20 divided doses q. 4 hr for 6=968 wk; rifampin, 300 mg p.o., q. 8 hr = for 6=968 wk;=20 gentamicin (administer during the initial 2 wk), 3 mg/kg I.M. or = I.V. daily=20 in divided doses q. 8 hr for 2 wk

              Staphylococci (Methicillin Resistant) in the = Presence of=20 Prosthetic Material

              • Vancomycin + rifampin + gentamicin=20
                • Dose: vancomycin, 30 mg/kg I.V. daily in = divided doses=20 q. 12 hr for 6=968 wk; rifampin, 300 mg p.o., q. 8 hr for 6=968 wk; = gentamicin=20 (administer during the initial 2 wk), 3 mg/kg I.M. or I.V. daily in = divided=20 doses q. 8 hr for 2 wk

                HACEK Organisms

                • Ceftriaxone or another third-generation = cephalosporin=20
                  • Dose: 2 g I.V. daily as a single dose for 4 = wk=20
                Surgical = Intervention=20
                • Indications for surgical debridement of = vegetations and=20 infected perivalvular tissue, with valve replacement or repair as=20 needed=20
                  • Moderate to severe heart failure=20
                  • Vegetations that obstruct the valve = orifice=20
                  • Perivalvular invasion and abscess = formation=20
                  • Uncontrolled infection for > 1=963 wk = despite maximal=20 antimicrobial therapy=20
                  • Fungal endocarditis=20
                  • Prosthetic valve endocarditis with = perivalvular=20 invasion=20
                  • Endocarditis caused by Pseudomonas = aeruginosa=20 or other gram-negative bacilli that has not responded after 7=9610 = days of=20 maximal antimicrobial therapy
                Endocarditis Associated with Parenteral Drug = Use=20
                • In intravenous drug users with isolated = right-sided=20 S. aureus endocarditis, surgery should be postponed and = antibiotic=20 therapy continued for a prolonged period
                  Antithrombotic Therapy=20
                  • Anticoagulants can cause or worsen hemorrhage = in=20 patients with endocarditis but may be carefully administered when=20 needed=20
                  • Prothrombin time should be carefully = maintained at INR=20 of 2.0=963.0=20
                  • Anticoagulation should be reversed immediately = in the=20 event of CNS complications and interrupted for 1=962 wk after acute = embolic=20 stroke=20
                  • Avoid heparin during active endocarditis if = possible=20

                  Best = References

                  Cabell, et al: Arch Intern Med 162:90, 2002
                  =20

                  Durack: JAMA 290:3250, 2003

                  Lisby, et al: Infect Dis Clin North Am 16:393,=20 2002

                  Olaison, et al: Cardiol Clin 21:235, = 2003

                  Towns, et al: Cardiol Clin 21:197, = 2003

                  March 2005


                  3D""=20=20 bac= k to=20 top
                  =A9 2008 BC Decker Inc. = All rights=20 reserved. =